TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
EWTX

Edgewise Therapeutics Inc

Healthcare · Biotechnology

41.20$ +0.2% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow EWTX
Line item 2019 2020 2021 2022 2023 2024 2025
– – – – – – –
– +50.4% +47.0% +97.8% +221.9% +32.2% -1.0%
– +359.7% +1,144.1% +148.0% +60.7% +40.7% +40.6%
– +359.7% +1,144.1% +148.0% – – –
– +483.8% +137.4% -11.7% -138.2% – -152.0%
– +12.8% +229.1% +730.2% +3.6% -77.2% -80.5%
– +13,445.0% +893.5% -70.9% – -279.5% -82.2%
– – – -30.3% – – –
– – – – – – –
– +385.0% +55.0% -30.4% -59.0% +368.8% -21.3%
– +426.0% -210.0% – +897.4% -169.3% –
– – – – – – –

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?